Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2008 1
2014 1
2016 3
2017 4
2018 1
2019 1
2021 1
2022 1
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Two heads are better than one: current landscape of integrating QSP and machine learning : An ISoP QSP SIG white paper by the working group on the integration of quantitative systems pharmacology and machine learning.
Zhang T, Androulakis IP, Bonate P, Cheng L, Helikar T, Parikh J, Rackauckas C, Subramanian K, Cho CR; Working Group. Zhang T, et al. Among authors: subramanian k. J Pharmacokinet Pharmacodyn. 2022 Feb;49(1):5-18. doi: 10.1007/s10928-022-09805-z. Epub 2022 Feb 1. J Pharmacokinet Pharmacodyn. 2022. PMID: 35103884 Free PMC article. Review.
A Quantitative Systems Pharmacology Model Describing the Cellular Kinetic-Pharmacodynamic Relationship for a Live Biotherapeutic Product to Support Microbiome Drug Development.
Renardy M, Prokopienko AJ, Maxwell JR, Flusberg DA, Makaryan S, Selimkhanov J, Vakilynejad M, Subramanian K, Wille L. Renardy M, et al. Among authors: subramanian k. Clin Pharmacol Ther. 2023 Sep;114(3):633-643. doi: 10.1002/cpt.2952. Epub 2023 Jun 2. Clin Pharmacol Ther. 2023. PMID: 37218407
Quantitative modeling predicts competitive advantages of a next generation anti-NKG2A monoclonal antibody over monalizumab for the treatment of cancer.
Spinosa P, Musial-Siwek M, Presler M, Betts A, Rosentrater E, Villali J, Wille L, Zhao Y, McCaughtry T, Subramanian K, Liu H. Spinosa P, et al. Among authors: subramanian k. CPT Pharmacometrics Syst Pharmacol. 2021 Mar;10(3):220-229. doi: 10.1002/psp4.12592. Epub 2021 Feb 13. CPT Pharmacometrics Syst Pharmacol. 2021. PMID: 33501768 Free PMC article.
StrandAdvantage test for early-line and advanced-stage treatment decisions in solid tumors.
Sen M, Katragadda S, Ravichandran A, Deshpande G, Parulekar M, Nayanala S, Vittal V, Shen W, Phooi Nee Yong M, Jacob J, Parchuru S, Dhanuskodi K, Eyring K, Agrawal P, Agarwal S, Shanmugam A, Gupta S, Vishwanath D, Kumari K, Hariharan AK, Balaji SA, Liang Q, Robolledo B, Gauribidanur Raghavendrachar V, Oomer Farooque M, Buresh CJ, Ramamoorthy P, Bahadur U, Subramanian K, Hariharan R, Veeramachaneni V, Sankaran S, Gupta V. Sen M, et al. Among authors: subramanian k. Cancer Med. 2017 May;6(5):883-901. doi: 10.1002/cam4.1037. Epub 2017 Apr 3. Cancer Med. 2017. PMID: 28371134 Free PMC article.
Identification of a novel glucokinase mutation in an Indian woman with GCK-MODY.
Jha S, Siddiqui S, Waghdhare S, Dubey S, Krishna S, Subramanian K, Dikshit JB, Ravikiran L, Bhargava A. Jha S, et al. Among authors: subramanian k. Lancet Diabetes Endocrinol. 2016 Apr;4(4):302. doi: 10.1016/S2213-8587(16)00040-1. Lancet Diabetes Endocrinol. 2016. PMID: 27016322 No abstract available.
18 results